The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

August 10, 2022

Study Completion Date

August 10, 2022

Conditions
Reaction Time
Interventions
DIETARY_SUPPLEMENT

Treatment (CopaPrime+ (USANA Health Sciences)

Participants received and consumed 2 treatment tablets immediately following baseline testing, and one hour prior to post-treatment testing. Each tablet contained extracts of Bacopa monnieri (150 mg), Coffea arabica (50 mg), and Panax quinquefolius L. (50 mg)

OTHER

Placebo

Participants received and consumed 2 placebo tablets immediately following baseline testing, and one hour prior to post-treatment testing. Each tablet contained microcrystalline cellulose. The size, shape and appearance of the placebo tablet was identical to the treatment tablet.

Trial Locations (1)

84060

US Ski and Snowboard Center of Excellence, Park City

All Listed Sponsors
collaborator

U.S. Ski & Snowboard

UNKNOWN

lead

USANA Health Sciences

INDUSTRY

NCT05926050 - The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes. | Biotech Hunter | Biotech Hunter